HOME >> MEDICINE >> NEWS
New drug holds promise to block clots in people with artery disease

DALLAS, April 30 The first study of a new drug designed to block blood clot formation showed no major adverse effects in people with stable coronary artery disease, according to a report in todays rapid access issue of Circulation: Journal of the American Heart Association.

The compound, DX-9065a, inhibits the action of factor Xa, one of the thirteen known factors involved in forming blood clots in coronary arteries. Factor Xa activates an enzyme called thrombin, which promotes the conversion of fibrinogen into fibrin, a major component of blood clots.

This is the first clinical experience with a direct, selective, reversible factor Xa inhibitor in patients with coronary artery disease, says cardiology researcher Robert A. Harrington, M.D., of the Duke Clinical Research Institute, in Durham, N.C. Our findings should lay the groundwork for further investigation of this and other agents that inhibit factor Xa in people with atherothrombosis, ischemic heart disease, and those undergoing coronary bypass surgery.

Anticoagulants, or blood-thinning drugs, work by inhibiting the ability of the blood to clot. Blood clots lodged in the coronary arteries block blood flow to the heart and cause most heart attacks. Anticoagulant therapy is commonly prescribed for people with heart disease to prevent further clot formation. The biggest drawback for anticoagulant drugs has been the potential for bleeding complications The randomized, double blind, placebo-controlled study, dubbed XaNADU, involved 73 patients with stable coronary artery disease at 10 medical centers. Their median age was 63 years, and 29 percent were women. Most had suffered a prior heart attack or had undergone angioplasty or coronary artery bypass surgery. During the study, 15 patients received a placebo, while 58 people received one of four different doses of DX-9065a, administered continuously over 72 hours.

Incidence of bleeding was minor and usually around the inf
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
29-Apr-2002


Page: 1 2

Related medicine news :

1. Chemical cousin of anti-anxiety drugs holds promise for psoriasis treatment
2. Direct payments to households in poor countries could improve maternal & child health
3. Worlds largest scientific society holds regional meeting Sept. 29 - Oct. 2 in Fort Worth
4. Case Western Reserves Flight Nursing Academy holds camp for nurses in air medical services
5. Optical glucose sensor holds promise for diabetics and intensive care patients
6. Intl Assoc for Dental Research holds 83rd General Session
7. Blood-diverting catheter holds promise for stroke treatment
8. Overweight and obesity thresholds may be misleading for Asian populations
9. Baclofen holds promise for cocaine treatment
10. Study shows combining gene therapy and radiation holds promise
11. Drug holds promise as an alternative for sickle cell patients unable to tolerate standard treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... PARK, Minn. (PRWEB) , ... December 05, 2018 , ... ... original, engaging, personalized fitness content to the masses. Wellbeats , which has delivered ... has released a new Wellbeats consumer app. Available now in the Apple App ...
(Date:12/5/2018)... ... December 05, 2018 , ... Northeast Delta Human Services ... at North Monroe Baptist Church, 210 Finks Hideaway Rd, Monroe, LA 71203. , ... effort to educate and equip faith leaders to address substance abuse prevention, support ...
(Date:12/5/2018)... ... December 05, 2018 , ... Since PermaLip™ implants ... The implants are invisible to the naked eye, ensuring a natural look. “I always ... that there are no signs of implant visibility,” says Dr. Jessica Kulak, double board ...
(Date:12/5/2018)... ... 2018 , ... Northcentral University (NCU) has today announced the launch of two ... a weekly rolling basis to registered nurses, the Master of Science in Nursing ... will prepare degree candidates to become leaders in the high-demand field. , “In ...
(Date:12/5/2018)... ... 05, 2018 , ... Domenic Palmieri has been named chief ... be responsible for the executive oversight of operations for three core divisions within ... for this position,” Tom Doran, president, HM Insurance Group, said. “And while we ...
Breaking Medicine News(10 mins):
(Date:12/10/2018)... ... December 10, 2018 , ... Mothers Against Drunk Driving (MADD) announces ... 2000 after her 16-year-old daughter, Helen Marie, was killed by a drunk and drugged ... on a clear June afternoon. , “I landed in MADD’s capable lap, completely shattered,” ...
(Date:12/8/2018)... ... December 07, 2018 , ... Nationally, it is estimated ... have dental insurance benefits that are seriously lacking and make it challenging to get ... believes that dental care should be accessible and affordable to everyone, with or without ...
(Date:12/6/2018)... NEW YORK (PRWEB) , ... December 06, 2018 , ... ... According to health officials, 80% of those children had not gotten the vaccine. Vaccination ... age and older as flu shots reduce the severity of the illness if infected. ...
Breaking Medicine Technology:
Cached News: